$1.5 Billion is the total value of Invesco Private Capital's 10 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVGS | New | Navigator Holdings Ltd. | $626,907,000 | – | 23,270,508 | +100.0% | 41.77% | – |
| AGO | Assured Guaranty Ltd. | $350,134,000 | +25.8% | 14,842,488 | 0.0% | 23.33% | -21.0% | |
| BKU | Sell | Bankunited Inc. | $183,091,000 | -28.3% | 5,561,692 | -32.1% | 12.20% | -55.0% |
| XCO | Exco Resources Inc. | $167,287,000 | -21.2% | 31,504,077 | 0.0% | 11.15% | -50.5% | |
| SNBC | Sun Bancorp Inc. | $74,903,000 | -8.1% | 21,279,241 | 0.0% | 4.99% | -42.3% | |
| CACB | Cascade Bancorp | $59,982,000 | -10.3% | 11,468,750 | 0.0% | 4.00% | -43.7% | |
| 2978PS | E2Open, Inc. | $31,636,000 | +6.7% | 1,323,110 | 0.0% | 2.11% | -33.0% | |
| HLIT | Sell | Harmonic, Inc. | $3,307,000 | -11.3% | 448,058 | -7.7% | 0.22% | -44.4% |
| LPDX | LipoScience, Inc. | $3,078,000 | -15.0% | 724,213 | 0.0% | 0.20% | -46.6% | |
| CYCC | Cyclacel Pharmaceuticals | $468,000 | -5.6% | 116,316 | 0.0% | 0.03% | -41.5% | |
| CALD | Exit | Callidus Software, Inc. | $0 | – | -1,136,406 | -100.0% | -1.11% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAVIGATOR HOLDINGS LTD. | 24 | Q3 2019 | 99.0% |
| Sun Bancorp Inc. | 19 | Q4 2017 | 35.4% |
| Exco Resources Inc. | 19 | Q4 2017 | 24.9% |
| XENON PHARMACEUTICALS, INC. | 18 | Q1 2019 | 1.0% |
| Cascade Bancorp | 16 | Q1 2017 | 20.3% |
| E2Open, Inc. Common Stock | 7 | Q4 2014 | 3.1% |
| Cyclacel Pharmaceuticals k | 7 | Q4 2014 | 0.1% |
| Talmer Bancorp Inc | 6 | Q2 2015 | 20.5% |
| LipoScience, Inc. Common Stock | 6 | Q3 2014 | 0.5% |
| Harmonic, Inc. Common Stock | 5 | Q2 2014 | 0.4% |
View Invesco Private Capital's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| E2open Inc | February 06, 2015 | 671,123 | 2.3% |
| CALLIDUS SOFTWARE INC | February 14, 2011 | 1,601,406 | 5.0% |
| MONTPELIER RE HOLDINGS LTDSold out | February 14, 2011 | 0 | 0.0% |
| Cyclacel Pharmaceuticals, Inc. | April 07, 2006 | 931,313 | - |
| SIGMATEL INC | February 11, 2005 | 447,881 | 1.3% |
| HEALTH GRADES INCSold out | March 12, 2003 | 0 | 0.0% |
| ALLOS THERAPEUTICS INC | October 02, 2002 | 861,961 | 3.8% |
| HEALTHGRADES COM INCSold out | March 23, 2001 | 0 | 0.0% |
| REPEATER TECHNOLOGIES INC | February 27, 2001 | 2,164,656 | 9.3% |
| TRANSGENOMIC INC | February 27, 2001 | 2,292,426 | 10.7% |
View Invesco Private Capital's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2019-12-05 |
| 4 | 2019-11-27 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 3 | 2019-04-08 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
View Invesco Private Capital's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.